Company news
Mayinglong Pharmaceutical Group Co., Ltd. Class A (SSE:600993) news
Mayinglong Pharmaceutical Group Co., Ltd. Class A news releases on 6ix. Latest, Sep 9, 2026: "Mayinglong Pharmaceutical Group Co., Ltd."Announcement…
Press releases & updates
"Mayinglong Pharmaceutical Group Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing
September 8, 2026
"Mayinglong Pharmaceutical Group Co., Ltd."Announcement on Departure and Appointment of General Manager
August 25, 2026
"Mayinglong Pharmaceutical Group Co., Ltd."Announcement on Implementation of Dividend Distribution for 2025
July 28, 2026
"Mayinglong Pharmaceutical Group Co., Ltd."Announcement on the Listing and Trading of Restricted Shares from the Share Reform
July 16, 2026
"Mayinglong Pharmaceutical Group Co., Ltd."Announcement on Obtaining Drug Registration Certificate by Subsidiary
July 10, 2026
"Mayinglong Pharmaceutical Group Co., Ltd."Announcement on the Inclusion of the Company's Pharmaceutical Products in the "National Essential Medicines List"
July 9, 2026
"Mayinglong Pharmaceutical Group Co., Ltd."Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction
July 2, 2026
Announcement on Obtaining Drug Registration Certificate
June 25, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
June 17, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
June 9, 2026
Notice on Convening the 2025 Annual General Meeting
May 26, 2026
Announcement on Obtaining Drug Registration Certificate by Subsidiary
May 22, 2026
Announcement on Termination of the Transfer of Equity of Subsidiary Holding Company by the Holding Subsidiary
May 8, 2026
2025 Annual Report
April 24, 2026
Announcement on Transfer of Equity of Subsidiary Holding Company by the Holding Subsidiary
March 30, 2026
Announcement on Extending Usage Period for Credit Guarantee Limits for Some Subsidiaries
March 13, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
November 20, 2025
Report for Q3 2025
October 29, 2025
Announcement on Resolutions of the 21st Meeting of the 11th Board of Directors
August 28, 2025
Announcement on the Release of Pledge for Shares Held by the Controlling Shareholder
August 5, 2025
Announcement on Implementation of Dividend Distribution for 2024
July 31, 2025
Announcement on Resolutions of the 2024 Annual General Meeting
June 30, 2025
Announcement on Release of Pledge of Partial Shares of Controlling Shareholder
June 13, 2025
Announcement on Obtaining Drug Registration Certificate by Its Wholly-owned Subsidiary
June 9, 2025
Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction
June 6, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
May 28, 2025
Report for Q1 2025
April 25, 2025
Announcement on Resolutions of the 18th Meeting of the 11th Board of Directors
April 2, 2025
Announcement on Obtaining Notice of Approval for Drug Clinical Trial
December 6, 2024
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2024
December 2, 2024
Announcement on Release of Pledge and Re-pledge of Some Shares Held by Controlling Shareholders
November 18, 2024
Announcement on Resolution of the 17th Meeting of the 11th Board of Directors
November 15, 2024
Report for Q3 2024
October 25, 2024
Semi-annual Report in 2024
August 23, 2024
Announcement on Extending the Duration of Industrial Investment Fund
August 20, 2024
Announcement on Implementation of Dividend Distribution for 2023
July 19, 2024
Announcement on Resolutions of 2023 Annual General Meeting
June 18, 2024
Announcement on Convening Performance Meeting for 2023 and 1st Quarter of 2024
June 11, 2024
Announcement on Changing Name of Shareholder
June 4, 2024
Notice on Convening 2023 Annual General Meeting
May 28, 2024
Announcement on Attending Online Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction in 2024
May 10, 2024
Announcement on Resolutions of 12th Session of 11th Board of Directors
April 12, 2024
Announcement on Resolutions of 11th Session of 11th Board of Directors
December 28, 2023
Announcement on Release of Pledge and Re-Pledge of Some Shares by Controlling Shareholder
November 30, 2023
3rd Quarter Report of 2023
October 27, 2023
Announcement on Convening 2023 Semi-annual Performance Meeting
September 14, 2023
2023 Semi-annual Report
August 25, 2023
Announcement on Implementation of Dividend Distribution of 2022
July 21, 2023
Announcement on Adjusting Member of Special Committee
June 13, 2023
Notice on Convening 2022 Annual General Meeting
May 19, 2023